Intracerebroventricular administration of <it>N</it>-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in inflammatory pain
<p>Abstract</p> <p>Background</p> <p>The peptide neurotransmitter <it>N</it>-Acetylaspartylglutamate (NAAG) is the third most prevalent transmitter in the mammalian central nervous system. Local, intrathecal and systemic administration of inhibitors of enzym...
Saved in:
Main Authors: | Kozikowski Alan (Author), Yamamoto Tatsuo (Author), Zhou Jia (Author), Neale Joseph H (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2008-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endogenous N-acetylaspartylglutamate (NAAG) inhibits synaptic plasticity/transmission in the amygdala in a mouse inflammatory pain model
by: Vicini Stefano, et al.
Published: (2010) -
NAAG peptidase inhibition in the periaqueductal gray and rostral ventromedial medulla reduces flinching in the formalin model of inflammation
by: Yamada Toshihiko, et al.
Published: (2012) -
<i>N</i>-Acetylaspartylglutamate (NAAG) Pretreatment Reduces Hypoxic-Ischemic Brain Damage and Oxidative Stress in Neonatal Rats
by: Ewelina Bratek, et al.
Published: (2020) -
New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors
by: Chenkai Cui, et al.
Published: (2022) -
Investigating brain uptake of a non-targeting monoclonal antibody after intravenous and intracerebroventricular administration
by: Arthur J. Van De Vyver, et al.
Published: (2022)